Logo


Delhi HC allows Alembic, Natco Pharma to export Bayer drug ingredient

Alembic refused to comments on the issue as they said they had not seen a copy of the judgment, while Bayer and Natco Pharma remained unavailable for comments

Representative image Photo: Shutterstock
Representative image Photo: Shutterstock

The Delhi High Court on Monday allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in Bayer’s cancer drug Nexavar, and rivaroxaban, the active ingredient in its blood thinner medicine Xarelto for research and development (R&D) purpose. A divison Bench of Justice S Ravindra Bhat and Justice Sanjeev Sachdeva, agreeing with majority of the findings of a single judge bench allowing the exports, said the question of whether those samples were being sent only for research and development or not will have to be heard afresh by the ...